Workflow
上肢康复机器人
icon
Search documents
巴斯夫,签约人形机器人国家“小巨人”,沙特阿美已投!
DT新材料· 2025-08-18 16:05
Core Viewpoint - The rise of emerging industries in China is expected to lead the next decade of polymer applications, particularly in robotics and related materials [1]. Group 1: BASF and Fourier Collaboration - BASF signed a Memorandum of Understanding with Shanghai Fourier Intelligent Technology Co., Ltd. to explore new material solutions for robotics, focusing on engineering plastics, polyurethane, and thermoplastic polyurethane [2]. - This collaboration follows BASF's previous showcase of high-temperature nylon and TPU applications in robotics, indicating a strategic move into the robotics sector [2][4]. - The partnership is initiated by BASF's venture capital arm, marking its first collaboration in the robotics industry in China, with potential for future investments [6]. Group 2: Fourier's Market Position and Growth - Fourier, established in 2015, is a leading company in humanoid robotics in China, with a focus on rehabilitation robots and a global presence in over 40 countries [5]. - The company reported a 127% year-on-year growth in its rehabilitation robot business for 2024, with orders extending to the end of 2025 [5]. - Fourier's latest product, the Care-bot GR-3, features advanced human-robot interaction capabilities, showcasing the company's innovation in the field [5]. Group 3: Polymer Materials in Robotics - Various companies, including Jinfa Technology and Prit, are actively developing polymer materials for humanoid robots, with applications ranging from radar shells to actuator gears [8]. - Polyurethane is highlighted as an ideal material for electronic skin and can replace aluminum components in robots, enhancing performance while reducing weight [8]. - The demand for humanoid robots is projected to double annually, driven by technological advancements and market growth, presenting new opportunities for polymer material companies [9]. Group 4: Market Trends and Future Outlook - The robotics industry is experiencing significant growth, with many companies reporting 50% to 100% increases in revenue, driven by demand from the market [9]. - The collaboration between BASF and Fourier is expected to open new markets for polymer materials, particularly in the robotics sector [10].
首款陪伴型机器人亮相!傅利叶加速布局康养赛道,创始人坦言走入家庭还需很长时间
Hua Xia Shi Bao· 2025-08-10 00:47
Core Insights - Fourier aims to sell over 10,000 robots by Q1 2025, with a delivery target of 300 biped robots for this year [1] - The company is focusing on the elder care robot market, which is expected to experience explosive growth due to global aging [1][4] - The newly launched GR-3 robot features a user-friendly design aimed at reducing the mechanical feel and enhancing user interaction [2] Company Developments - Fourier has been active in the elder care sector since its establishment in 2015, providing services to over 3,000 institutions and hospitals across more than 60 countries [3] - The company has completed 12 rounds of financing, with the latest round in May 2023 raising up to 300 million yuan [3] - Fourier's product line includes upper and lower limb rehabilitation robots and various therapy systems, addressing a wide range of rehabilitation needs [3] Market Potential - The domestic elder care robot market is projected to exceed 30 billion yuan in 2024 and reach 50 billion yuan by 2025, with a compound annual growth rate of over 30% [4] - The aging population in China, with over 300 million people aged 60 and above, presents a significant demand for elder care solutions [4] Technological Challenges - Current elder care robots have limitations in intelligence and interaction capabilities, requiring improvements in real-time environmental perception and multi-modal interaction [5] - Safety concerns exist regarding physical interaction with humans, indicating a need for better force feedback control [5] Future Directions - Fourier is exploring applications beyond elder care, including guidance, consultation, and industrial sectors [6] - The GR-3 robot is designed for various scenarios, including research, education, and healthcare, with a focus on meeting diverse customer needs [6]
首款陪伴型机器人亮相!傅利叶加速布局康养赛道,创始人坦言走入家庭还需很长时间|聚焦2025WRC
Hua Xia Shi Bao· 2025-08-09 11:57
Core Insights - Fourier aims to sell over 10,000 robots by Q1 2025, with a delivery target of 300 biped robots for this year [2] - The company is focusing on the elder care robot market, which is expected to see explosive growth due to global aging [2][5] - The newly launched GR-3 robot emphasizes interaction and companionship, designed to reduce users' feelings of alienation [3] Company Overview - Fourier has been active in the elder care sector since its establishment in 2015, providing services to over 3,000 institutions and hospitals in more than 60 countries [4] - The company has completed 12 rounds of financing, with the latest round in May 2023 raising up to 300 million yuan [4] Market Potential - The domestic elder care robot market is projected to exceed 30 billion yuan in 2024 and reach 50 billion yuan by 2025, with a compound annual growth rate of over 30% [5] - The aging population in China, exceeding 300 million people aged over 60, presents a significant demand for elder care solutions [5] Technological Challenges - Current elder care robots have limitations in intelligence and interaction capabilities, requiring improvements in real-time environmental perception and understanding of non-structured commands [5] - Safety concerns exist regarding physical interactions with users, indicating a need for better force feedback control [5] Expansion into Other Markets - Fourier is not limiting itself to the elder care market, as it has begun exploring applications in guidance, consultation, and industrial sectors [6] - Collaborations with institutions like China Construction Bank and SAIC General Motors demonstrate the versatility of their robots in various environments [6]
傅利叶CEO顾捷:人形机器人将重构医疗康养服务场景
Sou Hu Cai Jing· 2025-05-17 12:51
Group 1 - The 2025 Shanghai Technology Festival opened in Zhangjiang, Shanghai, showcasing robots from Fourier, a company specializing in robotics [1] - The two featured robots, Fourier N1 and GR-2, attracted significant attention, highlighting the company's advancements in robotics technology [1][3] - Fourier N1 is a compact robot with a height of 1.3 meters and a weight of 38 kilograms, capable of running at a speed of 3.5 meters per second and has completed over 1000 hours of outdoor testing [3] Group 2 - Fourier GR-2 is a larger robot, standing at 1.75 meters and weighing 63 kilograms, equipped with advanced actuators and a self-developed dexterous hand, enabling versatile applications in various fields [3] - The company has been active in the medical robotics sector for ten years, with products deployed in over 3000 medical terminals globally [3][4] - Fourier has developed over 30 rehabilitation robot products, delivering thousands of units, and aims to expand the use of humanoid robots in rehabilitation hospitals and community health service centers in the next few years [4] Group 3 - The rehabilitation robots possess significant commercial and social value, with a large market potential, but they require advanced technology for effective human interaction [4] - The integration of the robot's "brain" and "cerebellum" is a current challenge, affecting real-time and rapid action generation [4] - The company is focused on building a robust industrial ecosystem through collaborations with hospitals, universities, and research institutions to shorten innovation cycles [5]
傅利叶顾捷:一个医疗级人形机器人产品落地要三到四年
虎嗅APP· 2025-05-11 09:36
Core Viewpoint - The article discusses the evolution and future prospects of Fourier, a company specializing in humanoid robots, particularly in the context of healthcare and rehabilitation, highlighting its journey from inception to becoming a key player in the field of embodied intelligence [3][5][6]. Company Development - Fourier was founded ten years ago, initially focusing on rehabilitation robots and later expanding into humanoid robots, with the first prototype being developed in 2022 [3][5]. - The company has launched several humanoid robots, including GR-1 and GR-2, and plans to release more products by the end of the year [5][6]. Market Environment - The market for humanoid robots faced skepticism in the past, with many investors viewing them as mere toys; however, recent advancements in large model technology have transformed the perception of embodied intelligence into a new growth area [4][6]. - The healthcare sector is seen as a critical application area for humanoid robots, with Fourier's existing presence in over 3,000 medical institutions providing a strong foundation for future developments [6][10]. Technological Advantages - Fourier's expertise in core components from rehabilitation robots is leveraged in humanoid robot development, maintaining a focus on dual-legged designs [6][10]. - The company emphasizes the importance of interactivity and human-centric design in both industrial and healthcare applications, aiming to enhance robots' perception and decision-making capabilities [7][10]. Future Applications - Humanoid robots are expected to play significant roles in rehabilitation, elderly care, and companionship, with a focus on interactive and cognitive training [8][10]. - The timeline for bringing a medical-grade humanoid robot from concept to market is estimated to be three to four years, considering the necessary validation and regulatory processes [9][10]. Competitive Differentiation - Fourier differentiates itself through its technological advancements, including force feedback technology and AI-driven motion capabilities, which allow for adaptive interactions with users [10][12]. - The company has accumulated a wealth of rehabilitation data, enabling it to understand user needs and refine its robots' functionalities [10][12]. Collaboration and Ecosystem - Fourier recognizes the need for collaboration within the industry, particularly in sensor technology and AI model development, to enhance the capabilities of humanoid robots [12][13]. - The company aims to build partnerships with AI firms to leverage existing infrastructures and adapt models for specific applications [13][15]. Market Strategy - Fourier intends to maintain its focus on the B2B market while exploring potential C2C opportunities as technology evolves, emphasizing the importance of efficiency and user empowerment [15][16]. - The company views its rehabilitation and humanoid robot segments as interconnected, with plans for diverse robot forms to meet various user needs [16].
傅利叶顾捷:一个医疗级人形机器人产品落地要三到四年
Hu Xiu· 2025-05-11 05:12
Core Viewpoint - Fourier has evolved from a rehabilitation robotics company to a general humanoid robotics company, marking its tenth anniversary with significant advancements in humanoid robot development, including the launch of GR-1 and GR-2 [1][2][3] Company Development - Founded ten years ago in Zhangjiang, Fourier initially focused on rehabilitation robots, becoming one of the first teams in China to commercialize exoskeleton robots for medical rehabilitation [1][2] - The first humanoid robot prototype was developed in 2022, with the official launch of GR-1 in July 2023 at the World Artificial Intelligence Conference [2][3] Market Environment - The humanoid robotics market faced skepticism from investors initially, with many viewing humanoid robots as mere toys [2] - The landscape has changed, with advancements in large model technology driving interest and investment in embodied intelligence as a new frontier [2][3] Technological Focus - Fourier's strategy emphasizes the integration of core components from rehabilitation robots into humanoid robots, maintaining a bipedal design and achieving mass production of bipedal humanoid robots in 2023 [3][7] - The company has accumulated extensive data and experience from over 3,000 medical institutions, enhancing its understanding of user needs [3][7] Future Applications - Humanoid robots are expected to play significant roles in rehabilitation, elderly care, and companionship, with a focus on interaction, perception, and decision-making capabilities [5][8] - The company envisions a range of applications in the medical field, from patient guidance to night ward companionship, and extending into community and home settings [8][9] Product Development Timeline - The development timeline for a medical-grade humanoid robot from concept to market is approximately three to four years, including prototype validation and regulatory approval [6][12] Competitive Advantage - Fourier's competitive edge lies in its early focus on force feedback technology, advanced algorithms for motion capabilities, and a deep understanding of human-robot interaction [7][10] - The company aims to collaborate with partners for sensor development and leverage existing AI infrastructure to enhance its robotic capabilities [9][10] Market Strategy - While currently focused on B2B applications, Fourier is open to exploring C2C opportunities as technology evolves, although no immediate plans for C2C products exist [11][12] - The company does not view its rehabilitation and humanoid robotics segments as separate but rather as interconnected within the broader field of embodied intelligence [12][13]